Lobbying client

INNOVA MEDICAL GROUP, INC.

Developer of diagnostic and screening tests

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
13
Filed by
3
Reported in-house
—
Reported by firms
$300,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2023

Filings

13 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination
1st Quarter 2023
STRATEGIES 360 $10,000 reported
1st Quarter - Termination
1st Quarter 2023
LIBERTAS CONSULTING — reported
1st Quarter - Reportreplaced
1st Quarter 2023
STRATEGIES 360 $30,000 reported
4th Quarter - Report
4th Quarter 2022
STRATEGIES 360 $50,000 reported
4th Quarter - Amendment
4th Quarter 2022
LIBERTAS CONSULTING $40,000 reported
3rd Quarter - Amendment
3rd Quarter 2022
LIBERTAS CONSULTING $40,000 reported
Registration
3rd Quarter 2022
LIBERTAS CONSULTING — reported
3rd Quarter - Report
3rd Quarter 2022
STRATEGIES 360 $50,000 reported
2nd Quarter - Report
2nd Quarter 2022
STRATEGIES 360 $50,000 reported
1st Quarter - Report
1st Quarter 2022
STRATEGIES 360 $50,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
STRATEGIES 360 5 $210,000
LIBERTAS CONSULTING 3 $80,000
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 1 $10,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.